Discover 3,625 paid clinical trials in Texas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Sponsor:
H. Lundbeck A/S
Location:
Code:
NCT06578585
Conditions
Migraine
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Ubrogepant
Lu AG09222
Placebo
Sponsor:
Arbor Research Collaborative for Health
Location:
Code:
NCT04970056
Conditions
Pancreas Cancer
Pancreas Cyst
Pancreatic Ductal Adenocarcinoma
Genetic Predisposition
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Sponsor:
Integrative Health Technologies, Inc.
Location:
Code:
NCT01855009
Conditions
Quality of Life
Body Mass Index
Eligibility Criteria
Sex: All
Age: 5 - 19
Healthy Volunteers: Accepted
Interventions
MannaBears
AlgaeCal Calcium
Calcium carbonate
Vitamin D3
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06817356
Conditions
Alcohol Use Disorder
Eligibility Criteria
Sex: All
Age: 21 - 65
Healthy Volunteers: Not accepted
Interventions
Mazdutide
Placebo
Sponsor:
University of North Carolina, Chapel Hill
Location:
Code:
NCT03554356
Conditions
Barrett Esophagus
Intestinal Metaplasia
Esophageal Dysplasia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CryoBalloon Focal Ablation System
Sponsor:
The University of Texas Health Science Center at San Antonio
Location:
Code:
NCT05960656
Conditions
Type 2 Diabetes
Type 1 Diabetes
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Empagliflozin 25 MG
Placebo
Pioglitazone 30mg
Pioglitazone 30mg + Empagliflozin (25 mg)
Sponsor:
Diamyd Medical AB
Location:
Code:
NCT05018585
Conditions
Type 1 Diabetes Mellitus
Eligibility Criteria
Sex: All
Age: 12 - 28
Healthy Volunteers: Not accepted
Interventions
Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Colecalciferol 2000 IU
Placebo
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT04895709
Conditions
Cervical Cancer
Gastric/Gastroesophageal Junction Adenocarcinoma
Microsatellite Stable Colorectal Cancer
Non-Small-Cell Lung Cancer
Squamous Cell Carcinoma of Head and Neck
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BMS-986340
BMS-936558-01
Docetaxel
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT05036109
Conditions
Colorectal Cancer
Colon Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Aspirin
Vitamin D
Diet
Physical Activity
Behavioral Support Counseling Sessions
With a broad healthcare network and leading medical research centers, Texas is a key location for a wide range of clinical trials. Major institutions such as MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and Texas Heart Institute are at the forefront of these studies.
Texas offers unique advantages for those participating in clinical trials. The state's diverse population provides a broad range of participants, which enhances the reliability and relevance of research findings. Texas is also known for its innovative research environment, with a strong focus on medical advancements and cutting-edge studies.
By choosing to participate in a clinical trial in Texas, you contribute to important medical research while benefiting from a well-established and supportive clinical research system.
Clinical trials in Texas cover a broad range of health conditions, offering participants the opportunity to contribute to medical advancements while accessing innovative treatments.
Texas is home to world-leading cancer research institutions, making it a key location for oncology trials. These trials offer access to innovative treatments, such as new drugs, immunotherapies, and advanced radiation techniques that are not yet widely available.
As a major center for oncology research, Texas conducts clinical trials that cover a broad spectrum of cancers, including breast cancer, lung cancer, leukemia, colorectal cancer, prostate cancer, and liver cancer. These trials emphasize the development of targeted therapies, advancements in immunotherapy, and the exploration of combination treatments to improve the effectiveness of current cancer treatments.
Texas plays a major role in researching treatments for neurological conditions, particularly in areas such as stroke prevention, Alzheimer’s disease, Parkinson's disease, epilepsy, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS).
Clinical trials in these areas focus on developing innovative therapies, such as new drugs, brain stimulation devices, and gene therapies, with the goal of slowing disease progression and improving early intervention strategies.
Heart disease is a leading cause of death across the United States, making cardiovascular clinical trials a top priority in Texas. These studies investigate conditions such as heart failure, coronary artery disease, hypertension, and atrial fibrillation.
Research centers are dedicated to developing new treatments and improving preventative measures to combat this widespread health issue, with the goal of reducing its impact on millions of people. Innovations being tested include next-generation heart devices, new cholesterol-lowering medications, and minimally invasive cardiovascular procedures, all aimed at reducing the impact of these conditions on the population.
Chronic conditions such as diabetes and obesity are significant health challenges across the United States. Clinical trials in Texas are essential for advancing the management and treatment of these widespread issues.
These trials play an important role in evaluating new diabetes medications, exploring weight-loss therapies, and developing advanced treatments for respiratory and kidney diseases. By focusing on these areas, Texas contributes to improving care and outcomes for long-term health conditions like Type 1 and Type 2 diabetes, asthma, and chronic obstructive pulmonary disease (COPD).
Infectious diseases remain a critical area of study in Texas, especially given the state’s role in COVID-19 vaccine research and other viral disease treatments. Several prominent research institutions and hospitals in Texas, such as The University of Texas Medical Branch (UTMB) in Galveston, Baylor College of Medicine in Houston, and the Texas Biomedical Research Institute in San Antonio, were involved in key phases of vaccine trials.
In addition to its significant role in the initial development of COVID-19 vaccines, clinical trials in the state are also focusing on several key areas such as evaluating the efficacy of antiviral drugs, and exploring new strategies for HIV/AIDS prevention. Research efforts also encompass other important areas such hepatitis C, tuberculosis, and influenza, aiming to improve treatments and prevention methods for these prevalent infectious diseases.
With rising awareness of mental health challenges, Texas is a growing center for clinical research aimed at improving treatment options for psychiatric and behavioral disorders. Clinical trials explore both pharmaceutical solutions and therapeutic interventions.
Clinical trials address conditions such as depression, anxiety disorders, PTSD, schizophrenia, and bipolar disorder. These studies focus on testing novel antidepressants, anxiety-reducing therapies, and psychotherapies, aiming to provide better treatment options for individuals facing mental health challenges.
Texas also supports clinical trials for rare diseases, offering new hope to patients with conditions that have limited treatment options. These studies often focus on genetic conditions and explore groundbreaking treatments like gene therapy.
Clinical trials cover conditions such as cystic fibrosis, Duchenne muscular dystrophy, rare cancers, and other inherited disorders. Research efforts focus on gene editing, enzyme replacement therapies, and drug development, pushing forward groundbreaking treatments for these often overlooked diseases.
In Texas, clinical trials are governed by strict local regulations and guidelines to ensure the highest standards of safety and ethics. The Texas Department of State Health Services oversees clinical trials to ensure they adhere to state and federal standards. Researchers must obtain Institutional Review Board (IRB) approval, which involves a thorough review of the study’s design, risks, and benefits to protect participant welfare.
Informed consent is a crucial element for participants, ensuring they receive detailed information about the trial's purpose, procedures, potential risks, and benefits before agreeing to take part. Additionally, stringent privacy regulations are in place to protect the confidentiality of participants' medical information, upholding high standards of data security throughout the research process.
Participating in clinical trials offers numerous benefits, including access to cutting-edge treatments and therapies that are not yet available to the general public. Participants often receive close monitoring and care from top medical professionals, ensuring a high level of attention and support throughout the study.
Additionally, involvement in clinical trials contributes to important medical research that can lead to advancements in treatment and care for future patients. By participating, individuals not only gain early access to potentially groundbreaking interventions but also play an important role in advancing scientific knowledge and improving healthcare outcomes for others.
Worried about the risks of participating in a clinical trial? Read our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: